Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain mechanisms in manic depression

B J Carroll1

  • 1Department of Psychiatry, Duke University Medical Center, Durham, NC.

Clinical Chemistry
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Bipolar disorder, or manic depressive illness, involves significant mood and behavioral shifts with a strong biological basis. Understanding its varied presentations and genetic factors is key to developing effective treatment models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A proof of concept case series of botulinum toxin a treatment for ischemic feet due to Raynaud's phenomenon.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026
Same author

Sulodexide in venous disease.

Journal of thrombosis and haemostasis : JTH·2018
Same author

A genome-wide association study of antidepressant response in Koreans.

Translational psychiatry·2015
Same author

Clinical science and biomarkers: against RDoC.

Acta psychiatrica Scandinavica·2015
Same author

A genome-wide association study of antidepressant response in Koreans.

Translational psychiatry·2015
Same author

Association of the choline acetyltransferase gene with responsiveness to acetylcholinesterase inhibitors in Alzheimer's disease.

Pharmacopsychiatry·2015
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
Same journal

Editor's Note: Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer.

Clinical chemistry·2026
Same journal

In Reply to Reflexing NT-proBNP for sFlt-1/PlGF Ratios That Fall into the Measurement Uncertainty for Preeclampsia Risk Classification.

Clinical chemistry·2026
See all related articles

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Manic depressive illness (bipolar disorder) is recognized for its strong biological underpinnings.
  • Bipolar disorder presents with dramatic fluctuations in mood, energy, activity, and behavior.
  • Theories on mood disorders must account for bipolar disorder, not solely unipolar depression.

Purpose of the Study:

  • To discuss shifts in the nosological concepts of manic depression in relation to other mood disorders.
  • To recommend the adoption of the Kraepelinian "spectrum" concept for understanding bipolar disorder.
  • To explore new genetic mechanisms and their relation to the phenotypic heterogeneity of bipolar disorder.

Main Methods:

  • Literature review and conceptual analysis of mood disorder classifications.

Related Experiment Videos

  • Emphasis on the variable clinical presentations of manic depressive illness.
  • Consideration of genetic mechanisms and phenotypic heterogeneity.

    • Main Results:

    • The study highlights the importance of the Kraepelinian spectrum concept in understanding bipolar disorder.
    • Variable clinical presentations of manic depressive illness are a key feature.
    • New genetic mechanisms are proposed as factors in phenotypic heterogeneity.

    Conclusions:

    • A renewed adoption of the Kraepelinian spectrum concept is recommended for classifying manic depression.
    • Understanding the diverse clinical presentations and genetic factors is crucial for bipolar disorder.
    • A three-component model correlating clinical symptom clusters with brain systems is considered.